|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.919
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.714
|
Human |
|
negative regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902443 |
3 |
0.572
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.490
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.475
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.468
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.430
|
Human |
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.429
|
Human |
|
chromatin organization
|
GO:0006325 |
206 |
0.392
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.374
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.369
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.344
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.343
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.336
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.335
|
Human |
|
regulation of antibacterial peptide production
|
GO:0002786 |
1 |
0.334
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.332
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.331
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.324
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.312
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.302
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.290
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.279
|
|
|
methylation
|
GO:0032259 |
134 |
0.271
|
|
|
histone modification
|
GO:0016570 |
159 |
0.245
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.228
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.227
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.223
|
Zebrafish |
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.222
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.218
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.218
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.213
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.211
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.209
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.206
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.201
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.201
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.200
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.199
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.193
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.192
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.187
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.187
|
Human |
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.185
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.185
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.184
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.183
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.183
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.182
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.179
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.178
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.176
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.170
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.169
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.166
|
|
|
activation of jnkk activity
|
GO:0007256 |
3 |
0.162
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.159
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.157
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.156
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.155
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.153
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.149
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.148
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.148
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.144
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.140
|
Human |
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.139
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.138
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.138
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.137
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.135
|
|
|
regulation of nik nf kappab signaling
|
GO:1901222 |
10 |
0.135
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.133
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.130
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.127
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.127
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.127
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.127
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.126
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.124
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.122
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.122
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.122
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.121
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.120
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.120
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.119
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.119
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.118
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.116
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.116
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.115
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.115
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.114
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.114
|
Human |
|
immune effector process
|
GO:0002252 |
321 |
0.113
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.113
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.108
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.107
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.105
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.105
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.105
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.104
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.102
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.101
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.100
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.100
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.099
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.098
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.098
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.098
|
|
|
gland development
|
GO:0048732 |
330 |
0.097
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.097
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.096
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.096
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.093
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.093
|
Human |
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.092
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.091
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.091
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.090
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.089
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.089
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.088
|
|
|
tube formation
|
GO:0035148 |
140 |
0.087
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.086
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.085
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.085
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.084
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.083
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.079
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.079
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.078
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.078
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.077
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.076
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.076
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.076
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.076
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.075
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.074
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.074
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.074
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.073
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.072
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.071
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.071
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.070
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.070
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.070
|
Human |
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.069
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.069
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.068
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.067
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.066
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
35 |
0.066
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.066
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.064
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.064
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.064
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.063
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.063
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.063
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.062
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.062
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.062
|
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.062
|
|
|
tube closure
|
GO:0060606 |
91 |
0.060
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.060
|
|
|
lung development
|
GO:0030324 |
164 |
0.060
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.060
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.060
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.059
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.059
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.058
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.058
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.057
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.057
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.056
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.054
|
|
|
negative regulation of synaptic vesicle exocytosis
|
GO:2000301 |
3 |
0.053
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.052
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.052
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.052
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.051
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.051
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.050
|
Zebrafish |
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.050
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.050
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.048
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.048
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.047
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.047
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.047
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.047
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.047
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.046
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.046
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.046
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.046
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.046
|
Zebrafish |
|
chromatin silencing
|
GO:0006342 |
15 |
0.046
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.045
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.045
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.045
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.044
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.044
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.044
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.044
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.044
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.043
|
|
|
negative regulation of necroptotic process
|
GO:0060546 |
9 |
0.043
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.043
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.043
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.043
|
|
|
liver development
|
GO:0001889 |
66 |
0.043
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.043
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.043
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.043
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.043
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.042
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.042
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.042
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.042
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.042
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.041
|
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.041
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.041
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.041
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.041
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.041
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.040
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.040
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.040
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.040
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.040
|
|
|
regulation of synaptic vesicle transport
|
GO:1902803 |
13 |
0.040
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.039
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.039
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.039
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.039
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.039
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.038
|
|
|
negative regulation of neurotransmitter secretion
|
GO:0046929 |
5 |
0.038
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.038
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.038
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.038
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.038
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.038
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.037
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.037
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.037
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.037
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.036
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.036
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.036
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.036
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.036
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.035
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.035
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.035
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.035
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.035
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.035
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.035
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.034
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.034
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.034
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.034
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.034
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.034
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.034
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.033
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.033
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.033
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.033
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.033
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.033
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.032
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.032
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.032
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.032
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.032
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.032
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.032
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.032
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.031
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.031
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.031
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.030
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.030
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.030
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.029
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.029
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.029
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.029
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.029
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.028
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.028
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.028
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.028
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.028
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.028
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.028
|
|
|
segmentation
|
GO:0035282 |
93 |
0.028
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.028
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.027
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.027
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.027
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.027
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.027
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
2 |
0.026
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
regulation of planar cell polarity pathway involved in axis elongation
|
GO:2000040 |
3 |
0.026
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.026
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.026
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.026
|
|
|
regulation of necrotic cell death
|
GO:0010939 |
13 |
0.026
|
|
|
positive regulation of rab gtpase activity
|
GO:0032851 |
7 |
0.026
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.026
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.025
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.025
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.025
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.025
|
|
|
positive regulation of t cell cytokine production
|
GO:0002726 |
5 |
0.025
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.025
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.024
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.024
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.024
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.024
|
|
|
neurofilament cytoskeleton organization
|
GO:0060052 |
10 |
0.024
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.024
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.024
|
|
|
regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902442 |
3 |
0.024
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.024
|
|
|
embryonic body morphogenesis
|
GO:0010172 |
10 |
0.024
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.024
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.023
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.023
|
|
|
positive regulation of antibacterial peptide biosynthetic process
|
GO:0006963 |
1 |
0.023
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.023
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.023
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.023
|
|
|
organ growth
|
GO:0035265 |
117 |
0.023
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.023
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.022
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.022
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.022
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.022
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.022
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.022
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.022
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.022
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.022
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.022
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.022
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
|
|
negative regulation of neurotransmitter transport
|
GO:0051589 |
7 |
0.022
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.022
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.022
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.022
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.021
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.021
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.021
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.021
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.021
|
Zebrafish |
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.021
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.021
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
29 |
0.021
|
|
|
kidney development
|
GO:0001822 |
213 |
0.021
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.021
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.021
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.021
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.021
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.021
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.021
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.020
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.020
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.020
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.020
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.020
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.020
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.020
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.020
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.020
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.020
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.020
|
|
|
regulation of peptidyl threonine phosphorylation
|
GO:0010799 |
12 |
0.019
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.019
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.019
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.019
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.019
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.019
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.019
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.019
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.019
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.019
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.019
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
negative regulation of t helper 1 cell differentiation
|
GO:0045626 |
3 |
0.019
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.019
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.019
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.019
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.019
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.019
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.018
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.018
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.018
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.018
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.018
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.018
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.018
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.018
|
|
|
face development
|
GO:0060324 |
38 |
0.018
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.018
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.018
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.018
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.018
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.018
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.018
|
|
|
positive regulation of nik nf kappab signaling
|
GO:1901224 |
7 |
0.018
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
regulation of synaptic vesicle exocytosis
|
GO:2000300 |
11 |
0.017
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.017
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.017
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.017
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.017
|
|
|
cognition
|
GO:0050890 |
149 |
0.017
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.017
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.017
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.017
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.017
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.017
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.017
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.017
|
|
|
dna modification
|
GO:0006304 |
50 |
0.017
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.016
|
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.016
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.016
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.016
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.016
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.016
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.016
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.016
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.016
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.016
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.016
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.016
|
|
|
memory
|
GO:0007613 |
58 |
0.016
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|